Rational design of a protecting group pattern in a glucosyl donor allows for the α-selective synthesis of biotinylated pentasaccharides corresponding to the fragment of the α-(1→6)-glucans of Helicobacter pylori.
Two disaccharides and one trisaccharide related to the galactoxylomannan (GalXMan) of Cryptococcus neoformans were synthesized for the first time. Their conformational behavior was studied using computer calculations along with NMR analysis.
The polysaccharide mannan is the main surface antigen of the cell wall of
Candida
fungi, playing an important role in the pathogenesis of diseases caused by these mycopathogens. Mannan has a complex, comb-like structure and includes a variety of structural units, with their combination varying depending on the
Candida
species and strain. Glucomannan, a polysaccharide from
Candida utilis
, contains terminal
α
-
d
-glucose residues attached to oligomannoside side chains. This paper describes the first synthesis of a pentasaccharide structurally related to
C. utilis
glucomannan fragment, which is an
α
-(1→2)-linked tetramannoside terminated at the non-reducing end by an
α
-
d
-glucopyranosyl residue. The pentasaccharide was obtained as a 3-aminopropyl glycoside, which made it possible to synthesize also its biotinylated derivative, suitable for various glycobiological studies. The most complicated step in the pentasaccharide synthesis was stereoselective 1,2-
cis
-glycosylation to attach the
α
-
d
-glucopyranosyl residue. This was accomplished using a glucosyl donor specially developed in our laboratory, the protecting groups of which provide the necessary
α
-stereoselectivity. The target biotinylated pentasaccharide thus obtained will be used in the future as a model antigen for the detection of immunodeterminant epitopes of
Candida
mannans.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.